Tatva Chintan Pharma Chem (Small Cap) Share Target 2024, 2025 To 2039
|
Tatva Chintan Pharma Chem Limited |
|||
|
Price: ₹812.95 | ||
| 52 Week Low: ₹788.50 52 Week High: ₹1,650.85 |
|||
| Market Capital: 2,611.95 Crore (Smallcap) | |||
| Basic Materials -> Specialty Chemicals | |||
Show Table of Contents
Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: Tatva Chintan Pharma Chem Share Price Target For 2024
- 1.1.1: Tatva Chintan Pharma Chem Share Price Target Table For 2024
- 1.1.2: Short-Term Technical Outlook
- 1.2: Tatva Chintan Pharma Chem Share Price Target For 2025
- 1.2.1: Tatva Chintan Pharma Chem Share Price Target Table For 2025
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: Tatva Chintan Pharma Chem Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
- 3: Tatva Chintan Pharma Chem Brief Company Overview
- 4: Tatva Chintan Pharma Chem Financial Performance
- 4.0.1: Is Tatva Chintan Pharma Chem A Good Buy For Long Term?
To predict the Tatva Chintan Pharma Chem's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Tatva Chintan Pharma Chem Share Price Target For 2024
The line chart displays the monthly closing prices of Tatva Chintan Pharma Chem with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Tatva Chintan Pharma Chem shares in 2024, see the table below.
Tatva Chintan Pharma Chem Share Price Target Table For 2024
| Level | Value | Analysis |
|---|---|---|
| 2024 Target 3 | 856.79 (+5.39%) | Price Action: 31 Oct 2024 High |
| 2024 Target 2 | 845.0 (+3.94%) | Price Action: 18 Nov 2024 High |
| 2024 Target 1 | 835.0 (+2.71%) | Price Action: 20 Dec 2024 Low |
| Current Price | 812.95 | Tatva Chintan Pharma Chem's share price as of 23 Dec 2024 |
| Stop Loss 1 | 802.5 (-1.29%) | Price Action: 21 Nov 2024 Low |
| Stop Loss 2 | 788.5 (-3.01%) | Price Action: Oct 2024 Low |
| Stop Loss 3 | 774.03 (-4.79%) | Fibonacci Retracement Level 28.20% |
Short-Term Technical Outlook
Current Technical Position: Tatva Chintan Pharma Chem is displaying bearish momentum trading below key moving averages.
Key Technical Level: The 25-day moving average at ₹865.87 serves as the nearest technical reference point.
Historical Returns: 3-month: -19.59% | 6-month: -23.53% | 1-year: -47.25%
Tatva Chintan Pharma Chem Share Price Target For 2025
The line chart displays the monthly closing prices of Tatva Chintan Pharma Chem with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Tatva Chintan Pharma Chem shares in 2025, see the table below.
Tatva Chintan Pharma Chem Share Price Target Table For 2025
| Level | Value | Analysis |
|---|---|---|
| 2025 Target 3 | 1410.42 (+73.48%) | Price Action: Chart |
| 2025 Target 2 | 1384.12 (+70.25%) | Price Action: Chart |
| 2025 Target 1 | 1370.42 (+68.56%) | Fibonacci Extension Level 64.90% |
| Current Price | 812.95 | Tatva Chintan Pharma Chem's share price as of 23 Dec 2024 |
| Stop Loss 1 | 677.19 (-16.7%) | Price Action: Chart |
| Stop Loss 2 | 670.42 (-17.54%) | Price Action: Chart |
| Stop Loss 3 | 658.35 (-19.02%) | Price Action: Chart |
Long-Term Technical Outlook
52-Week Range Analysis: Tatva Chintan Pharma Chem is currently trading near its 52-week low of ₹788.5, indicating potential value opportunity.
Long-Term Trend Analysis: The stock is in a bearish long-term trend, trading below key long-term moving averages.
Long-Term Performance: 1-year: -47.25% | 3-year: -68.12% | 5-year: NA
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Tatva Chintan Pharma Chem Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
| Year | Target 1 | Target 1 YoY Chg % | Target 2 |
|---|---|---|---|
| Current Price | ₹812.95 | ||
| 2024 | ₹735.48 | -9.52% | ₹787.51 |
| 2025 | ₹695.31 | -5.46% | ₹705.74 |
Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.
Tatva Chintan Pharma Chem Brief Company Overview
Tatva Chintan Pharma Chem Limited: A Leading Specialty Chemicals Manufacturer Established in 1996, Tatva Chintan Pharma Chem Limited is a renowned manufacturer and supplier of specialty chemicals in India, catering to diverse industries. Key Products and Services: ...
Structure directing agents for zeolites synthesis Phase transfer catalysts Electrolyte salts for super capacitors and zinc ion batteries Pharmaceutical APIs, agrochemical products Intermediates, disinfectants, catalysts, solvents Market Presence: Tatva Chintan has a strong global presence, exporting its products to over 20 countries, including the US, China, and Europe. Commitment: The company is committed to innovation and customer satisfaction, providing high-quality products and technical support to its clients.Tatva Chintan Pharma Chem Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 2,611.95 Crore | Market valuation of Tatva Chintan Pharma Chem's shares. |
| Revenue (TTM) | 393.5 Crore | Total revenue generated by Tatva Chintan Pharma Chem over the past twelve months. |
| Net Income (TTM) | +30.35 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | +9.53% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | +7.71% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) |
-21.1% | Change in revenue compared to the previous quarter. |
| Earnings Growth (YOY Quarterly) |
-43.3% | Change in earnings compared to the same quarter last year. |
| Debt-to-Equity (D/E) Ratio |
1.93 | Company's total debt divided by total shareholder equity. |
| Total Debt | 14.27 Crore | Sum of Tatva Chintan Pharma Chem's current & long-term financial obligations. |
| Total Cash | 48.34 Crore | Total amount of liquid funds available to Tatva Chintan Pharma Chem. |
| Beta | -0.1 | Beta is less than 1 indicating that the Tatva Chintan Pharma Chem's price is less volatile than the market. |
Is Tatva Chintan Pharma Chem A Good Buy For Long Term?
Tatva Chintan Pharma Chem, with a market cap of 2,611.95 Crore, has seen a revenue decline of 21.1% in Q4-2023-24 compared to the previous quarter and a net profit drop of 43.3% compared to the same quarter last year. Despite a positive profit margin of 7.71%, the company's negative returns over various time frames indicate a challenging period. Considering these factors, this stock may not be a strong buy for long-term investment at this time.
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
